+ Follow ADJUVANT Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 275629
[Title] => Adjuvant treatment for colon cancer OK’d
[Summary] => European authorities recently approved capecitabine, an innovative oral chemotherapy, as an adjuvant treatment (post-surgery) for colon cancer.
The drug has been shown to prolong cancer-free survival with less serious side effects compared to standard current treatment.
Adjuvant chemotherapy is a standard treatment approach for stage III colon cancer to destroy cancer cells remaining in the body after the tumor has been surgically removed.
[DatePublished] => 2005-04-28 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 253305
[Title] => Renewed hope for patients with early breast cancer
[Summary] => Promising new data from a landmark study demonstrated an impressive 40 percent reduction in the risk of distant breast cancer recurrences, or metastases, with extended adjuvant letrozole in post-menopausal women with early breast cancer.
These data were presented during the "Best of Oncology" session in this year’s annual meeting of the American Society of Clinical Oncology (ASCO).
Distant metastases are a well-established risk factor for breast cancer death.
[DatePublished] => 2004-06-10 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
ADJUVANT
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 275629
[Title] => Adjuvant treatment for colon cancer OK’d
[Summary] => European authorities recently approved capecitabine, an innovative oral chemotherapy, as an adjuvant treatment (post-surgery) for colon cancer.
The drug has been shown to prolong cancer-free survival with less serious side effects compared to standard current treatment.
Adjuvant chemotherapy is a standard treatment approach for stage III colon cancer to destroy cancer cells remaining in the body after the tumor has been surgically removed.
[DatePublished] => 2005-04-28 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 253305
[Title] => Renewed hope for patients with early breast cancer
[Summary] => Promising new data from a landmark study demonstrated an impressive 40 percent reduction in the risk of distant breast cancer recurrences, or metastases, with extended adjuvant letrozole in post-menopausal women with early breast cancer.
These data were presented during the "Best of Oncology" session in this year’s annual meeting of the American Society of Clinical Oncology (ASCO).
Distant metastases are a well-established risk factor for breast cancer death.
[DatePublished] => 2004-06-10 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
